Lonza Group AG (LZAGF)
OTC Markets OTCPK - OTC Markets OTCPK Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
| Previous close | 0.00 |
| Open | 629.00 |
| Bid | 609.90 x 1800 |
| Ask | 645.35 x 1400 |
| Day's range | 629.00 - 629.00 |
| 52-week range | 336.03 - 678.80 |
| Volume | |
| Avg. volume | 153 |
| Market cap | 45.169B |
| Beta (5Y monthly) | 0.65 |
| PE ratio (TTM) | 65.33 |
| EPS (TTM) | 9.39 |
| Earnings date | 25 Jul 2024 |
| Forward dividend & yield | 4.41 (0.72%) |
| Ex-dividend date | 13 May 2024 |
| 1y target est | N/A |
ZacksAll You Need to Know About Lonza Group (LZAGY) Rating Upgrade to Strong Buy
Lonza Group (LZAGY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
ZacksESLOY or LZAGY: Which Is the Better Value Stock Right Now?
ESLOY vs. LZAGY: Which Stock Is the Better Value Option?
- GuruFocus.com
Acumen Pharmaceuticals Inc (ABOS) (Q1 2024) Earnings Call Transcript Highlights: Strategic ...
Explore key insights from Acumen Pharmaceuticals' Q1 2024 earnings, focusing on their innovative Alzheimer's treatments and financial outlook.
© 2024 Yahoo. All rights reserved.